Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Weisel, Katja; Spencer, Andrew; Lentzsch, Suzanne et al.
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic riskJOURNAL OF HEMATOLOGY & ONCOLOGY. Bd. 13. H. 1. 2020
Sangro, Bruno; Chan, Stephen L.; Meyer, Tim et al.
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinomaJOURNAL OF HEPATOLOGY. Bd. 72. H. 2. 2020 S. 320-341
Triantafyllias, Konstantinos; Heller, Caroline; de Blasi, Michele et al.
Diagnostic Value of Optical Spectral Transmission in Rheumatoid Arthritis: Associations with Clinical Characteristics and Comparison with Joint UltrasonographyJOURNAL OF RHEUMATOLOGY. Bd. 47. H. 9. 2020 S. 1314-1322
Hoetker, Andreas M.; Lollert, Andre; Mazaheri, Yousef et al.
Diffusion-weighted MRI in the assessment of nephroblastoma: results of a multi-center trialABDOMINAL RADIOLOGY. Bd. 45. H. 10. 2020 S. 3202-3212
Goetze, E.; Thiem, D. G. E.; Gielisch, M. et al.
Digitalization and use of artificial intelligence in microvascular reconstructive facial surgeryCHIRURG. Bd. 91. H. 3. 2020 S. 216-221
Rodriguez-Alvarez, M.; Sarmini, L.; Kim, D. et al.
Direct detection f mutatins arising at a damage sith in DNANAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 393. H. SUPPL 1. 2020 S. 4-4
Messerschmidt, Clemens; Obermayer, Benedikt; Klinghammer, Konrad et al.
Distinct immune evasion inAPOBEC-enriched,HPV-negativeHNSCCINTERNATIONAL JOURNAL OF CANCER. Bd. 147. H. 8. 2020 S. 2293-2302
Degenhardt, Tom; Harbeck, Nadia; Fasching, Pater A. et al.
Documentation patterns and impact on observed side effects of the CANKADO ehealth application: An exploratory analysis of the PreCycle trial.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
Weiland, Thomas; Eckert, Alexander; Tomazic, Peter Valentin et al.
DRH1 - a novel blood-based HPV tumour markerEBIOMEDICINE. Bd. 56. 2020
Viardot, Andreas; Hess, Georg; Bargou, Ralf C. et al.
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphomaLEUKEMIA & LYMPHOMA. 2020